Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edwin Rubel, PhD
Oricula Therapeutics
Principal Investigator - Kevin L Winthrop, MD, MPH
Oregon Health and Science University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Francisco
San Francisco, California, United States
Catherine DeVoe, MDShoshana Zha, MD, PhDRecruiting - National Jewish Health
Denver, Colorado, United States
Charles L Daley, MDRecruiting - Johns Hopkins University
Baltimore, Maryland, United States
Elisa Ignatius, MD, MScNot, yet, recruiting - Mayo Clinic
Rochester, Minnesota, United States
Timothy Aksamit, MDRecruiting - Northwell Health
Manhasset, New York, United States
Lisa Hayes, MDMarcia Epstein, MDNot, yet, recruiting - Oregon Health & Science University
Portland, Oregon, United States
Kevin Winthrop, MD, MPHRecruiting - Medical University of South Carolina
Charleston, South Carolina, United States
Patrick Flume, MDRecruiting - University of Texas Health Science Center
Tyler, Texas, United States
Devanshi Mehta, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Jun 2025
- Primary completion
- 29 Feb 2028
- Completion
- 29 Feb 2028
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 105
- Registry id
- NCT05730283
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.